See other articles
Apr 17, 2026
May 06, 2026
The poster showcases the compelling results of our collaboration with AstraZeneca:
Share your email with us and we will deliver the material to your inbox:
Share your details with us and we will deliver the case study Development and validation of a customized, functional STRIDE®-based assay to measure Mismatch Repair (MMR) pathway activity in cells to your inbox.
Share your details with us and we will deliver the case study Studying the effects of alpha and beta-emitters alone and in combination with a DDR inhibitor in a human cell line model to your inbox.
Share your details with us and we will deliver the case study Studying the MoA of a DDR inhibitor in Patient-Derived Xenograft (PDX) models using STRIDE® to your inbox.
Share your details with us and we will deliver the poster Measuring the activity of SMUG1 DNA glycosylase with a novel sSTRIDE-SMUG1 assay to your inbox.
Share your details with us and we will deliver the poster Novel dSTRIDE-HR™ assays can accurately assess DNA repair defects in human cancers and distinguish HR status of tumors to your inbox.
Share your details with us and we will deliver the whitepaper to your inbox.
The poster showcases the compelling results of our collaboration with AstraZeneca:
Share your email with us and we will deliver the material to your inbox:
Share your details with us and we will deliver the case study Development and validation of a customized, functional STRIDE®-based assay to measure Mismatch Repair (MMR) pathway activity in cells to your inbox.
Share your details with us and we will deliver the case study Studying the effects of alpha and beta-emitters alone and in combination with a DDR inhibitor in a human cell line model to your inbox.
Share your details with us and we will deliver the case study Studying the MoA of a DDR inhibitor in Patient-Derived Xenograft (PDX) models using STRIDE® to your inbox.
Share your details with us and we will deliver the poster Measuring the activity of SMUG1 DNA glycosylase with a novel sSTRIDE-SMUG1 assay to your inbox.
Share your details with us and we will deliver the poster Novel dSTRIDE-HR™ assays can accurately assess DNA repair defects in human cancers and distinguish HR status of tumors to your inbox.
Share your details with us and we will deliver the whitepaper to your inbox.